Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment

NCT02082756 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The sponsor have not enough money to support this trial

Conditions

Prediabetes

Interventions

DRUG: Bifidobacterium viable pharmaceutics
DRUG: Berberine Hydrochloride

Sponsor

Xijing Hospital